Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1109.0000 -15.80 (-1.40%)
NSE Oct 15, 2025 15:31 PM
Volume: 543.5K
 

1109.00
-1.40%
BOB Capital Markets Ltd.
SIEM:Strong topline, margins waver. EIM: Launch momentum continues. ARBP:Strong margin uptick. CRS: Weak quarter on soft demand, marketing expense. HINDWARE: Tough quarter but outlook healthy. Power: CERC draft tariff norms: Balancing risk-reward. Power: Q3FY24 Review - Spotlight on capacity additions
Aurobindo Pharma Ltd. has lost -25.53% in the last 1 Year
More from Aurobindo Pharma Ltd.
Recommended